In various clinical trials, tenofovir alafenamide (TAF) has demonstrated...
In various clinical trials, tenofovir alafenamide (TAF) has demonstrated improvement in markers of renal dysfunction in individual randomised trials...
12 Apr, 2019
In a recent study, researchers analyzed the data from 20 cohorts in the Collaboration of Observational HIV Epidemiological Research Europe (COHERE)...
26 Mar, 2019
There is growing evidence on tenofovir disoproxil fumarate (TDF)-associated nephrotoxicity, however, its use in the management of HIV-1 infection is...
15 Feb, 2019
A number of factors including chronic inflammation, immune activation, traditional risk factors and exposure to antiretroviral drugs are reported to...
12 Feb, 2019
This trial compares the safety and efficacy of TAF vs TDF co-formulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of...
This study compared the enhanced and standard antimicrobial prophylaxis treatment in patients with advanced HIV disease.
Pre-exposure Prophylaxis Initiative (iPrEx) trial was a randomized, double-blind, placebo controlled trial aimed to evaluate the safety and efficacy...
The Partners PrEP Study is a double-blind, placebo-controlled, phase III clinical trial aimed to assess the safety and efficacy of oral PrEP for the...
Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...
Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...
Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...
This slide set covers the epidemiology, disease progression and management of HIV-HCV coinfection in the era of directly acting antivirals available...
PrEP is the use of an antiretroviral medication by HIV-negative individuals to prevent them from acquiring HIV. These slides give an overview on the...
Post-exposure prophylaxis (PEP) is the method of preventing exposures of HIV to blood and body fluids and it is considered to be the most important...
HIV is the strongest risk factor for developing tuberculosis (TB) disease in those with latent or new Mycobacterium tuberculosis infection....